Skip to main content
Abridge logo

Abridge

🔥 HOT
Updated Mar 23, 2026

How Abridge stacks up in AI Healthcare — funding data, key investors, and more.

🇺🇸United StatesSeries EAI Healthcare

Out of 100

🇺🇸

HQ

United States

🗓

Founded

2018

💰

Raised

$800M

🏷️

Stage

Series E

👥

Team

120

Abridge is an AI health company founded in 2018 that develops clinical documentation and conversation intelligence tools for healthcare providers. The company's core product uses artificial intelligence to automatically generate clinical notes from patient-physician conversations, addressing the administrative burden that consumes significant physician time. Abridge's technology uses natural

Is this your company? Claim it →

Key Facts

  • Abridge is valued at $5.3B as of March 2026.
  • Abridge has raised a total of $800M in disclosed funding across 4 funding rounds.
  • Abridge was founded in 2018 by Shiv Rao and is headquartered in United States.
  • Abridge employs approximately 120 people.
  • Abridge operates in the AI Healthcare category and is currently at the Series E stage.
  • Abridge has an Awaira Score of 76/100, ranking it among the tracked AI companies on Awaira.
  • Abridge's most recent funding round was a Series C of $150M closed in January 2023.

Source: Awaira · Updated Mar 23, 2026

$5.3B

Post-money

$800M

All rounds

76/100

2018

120 employees

Strengths

Unicorn status with $5.3B valuation

Strong Awaira Score of 76/100

Growing team of 120 employees

Analysis based on publicly available data. Not investment advice.

4

Total Rounds

$69M

Avg Round Size

4.1yr

Funding Span

Abridge raised 4 rounds over 4.1 years, averaging $69M per round — a pace of roughly one round every 12 months.

⚠️ ESTIMATE
💵Est. Annual Revenue
$50M–$500M estimated ARR

Awaira estimate based on public data. Not financial advice.

How does Abridge stack up against competitors?

MetricAbridgeButterfly NetworkTempusAlan
Awaira Score76/10085/10084/10083/100
Total Raised$800M$370M$1.05B$750M
Valuation$5.3B$957M$8.1B$5.83B
StageSeries EPublicPublicSeries D
Founded2018201120152016
Employees120500-10002500500-1000
Country🇺🇸🇺🇸🇺🇸🇫🇷
S

Shiv Rao

Founder & CEO

View founder profile →
StageSeries E
Employees120
Country🇺🇸 United States
Connect
Inactive
4 rounds
Series CLatest

Kleiner Perkins, Lerer Hippeau, Khosla Ventures

$150M

Jan 2023

Series B

$30M

Jan 2022

Series A

Kleiner Perkins, Khosla Ventures

$27M

Jan 2021

Seed

Undisclosed

Jan 2019

Frequently Asked Questions

What is Abridge's valuation?
The current market valuation is approximately $5.3B, based on publicly available funding data.
Who invested in Abridge?
On the cap table: Kleiner Perkins, Lerer Hippeau, Khosla Ventures. Their combined backing has helped fund operations and expansion.
When did Abridge last raise funding?
Capital was most recently raised through a Series C of $150M in January 2023.
How many employees does Abridge have?
The team is roughly 120 people, headquartered in United States.
What does Abridge do?
Abridge is an AI health company founded in 2018 that develops clinical documentation and conversation intelligence tools for healthcare providers. The company's core product uses artificial intelligence to automatically generate clinical notes from patient-physician conversations, addressing the administrative burden that consumes significant physician time. The company operates in the AI Healthcare sector from United States.
Who founded Abridge?
Behind the company is Shiv Rao, who got it off the ground in 2018 in United States. Shiv Rao serves as Founder & CEO.
Is Abridge profitable?
Whether the company is profitable hasn't been confirmed publicly. It has raised $800M in total funding and is classified at the Series E stage.
Where is Abridge headquartered?
Home base is United States 🇺🇸. The AI Healthcare company was founded in 2018 and operates from there.
⚔️

Compare Abridge

See how Abridge stacks up against competitors in valuation, funding, team size, and Awaira Score.

Browse all comparisons →